C4:0 1.21 1.27 0.03 +
C6:0 1.99 1.99 0.05 NS
C8:0 2.73 2.59 0.08 NS
C10:0 10.83 8.97 0.25 ***
C12:0 6.30 4.30 0.15 ***
C14:0 11.28 8.66 0.18 ***
C14:1 0.22 0.13 0.02 ***
C15:0 0.97 0.79 0.02 ***
C16:0 27.46 22.57 0.41 ***
C16:1 0.64 0.50 0.02 ***
C17:0 0.65 0.56 0.01 ***
C17:1 0.22 0.12 0.02 ***
C18:0 9.09 12.41 0.35 ***
Trans-9 C18:1 0.18 0.74 0.05 ***
Trans-11 C18:1 (TVA3
) 2.04 6.41 0.27 ***
Cis-9 C18:1 17.82 19.56 0.35 ***
Cis-11 C18:1 0.56 0.80 0.02 ***
Trans-10, trans-12 C18:2 0.31 0.42 0.02 ***
Cis-9, cis-12 C18:2 2.91 3.32 0.01 **
Cis-9, trans-11 C18:2 (CLA4
) 0.68 2.03 0.04 ***
C18:3 0.69 0.62 0.02 ***
C20:0 0.26 0.29 0.01 ***
Other 0.89 0.88 0.07 NS
n-6:n-3 4.69 6.12 0.16 ***
Short-chain FA (C4 to C10) 16.90 14.91 0.38 **
Medium-chain FA (C12 to C16) 47.04 37.09 0.59 ***
Long-chain FA (>C16) 35.10 46.94 0.77 ***
Saturated FA 72.84 64.47 6.47 ***
Unsaturated FA 26.27 34.65 0.52 ***
Monounsaturated FA 19.63 27.87 0.37 ***
Polyunsaturated FA 4.60 6.40 0.12 ***
TVA:CLA 2.99 3.17 0.18 NS
Atherogenicity index5 3.29 2.20 0.08 ***
Δ9
-Desaturase ratio6
C14 0.017 0.014 0.001 *
C16 0.023 0.021 0.001 NS
C18 0.69 0.69 0.006 NS
CLA 0.26 0.25 0.015 NS